Nitnib 12.5mg

Nitnib 12.5mg Capsule contains the active ingredient Sunitinib. It is categorized as a tyrosine kinase inhibitor, meaning it functions by inhibiting specific enzymes known as tyrosine kinases that play a role in the development and dissemination of cancer cells. This medication is utilized for the treatment of gastrointestinal stromal tumors (GIST), a rare type of cancer that can originate anywhere within the gastrointestinal tract. Additionally, it is prescribed for advanced kidney cancer and pancreatic cancer, specifically pancreatic neuroendocrine tumors (PNET). Cancer is characterized by the uncontrolled growth of abnormal cells. It is not advisable for individuals under the age of 18.

Prior to using Nitnib 12.5mg Capsule, it is crucial to consult with your physician if you have any blood disorders, heart issues, liver conditions, kidney ailments, skin problems, diabetes, seizures, or thyroid issues. Also, notify your doctor if you have recently undergone surgery or are scheduled for surgery. Inform your healthcare provider if you have hypertension, as this medication can occasionally lead to elevated blood pressure as a side effect. It is recommended to avoid grapefruit in any form while undergoing treatment with Nitnib 12.5mg Capsule. Consult your dentist if you experience any oral issues, such as pain, swelling, or sores in the mouth, before commencing treatment.